Candriam Equities L Biotechnology Class C USD Cap

Register to Unlock Ratings
Performance History31/08/2021
Growth of 1,000 (GBP) Advanced Graph
Candriam Equities L Biotechnology Class C USD Cap
Fund15.7-5.729.815.63.0
+/-Cat5.42.29.6-10.40.6
+/-B’mrk4.6-2.59.5-7.0-9.1
 
Key Stats
NAV
16/09/2021
 USD 823.21
Day Change 0.63%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0108459040
Fund Size (Mil)
16/09/2021
 USD 2004.58
Share Class Size (Mil)
16/09/2021
 USD 434.25
Max Initial Charge 3.50%
Ongoing Charge
11/05/2021
  1.88%
Morningstar Research
Analyst Report

A growing team of highly qualified biotechnology experts led by one of the industry’s most seasoned investors in the field and a proven process give this fund an edge. The fund’s cheapest share classes receive a Morningstar Analyst Rating of...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
PeopleAbove Average
ParentAverage
ProcessAbove Average
Performance
Price
Investment Objective: Candriam Equities L Biotechnology Class C USD Cap
The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund enables shareholders to invest in a portfolio of global equities in the biotechnology sector. The assets will be invested principally in the equities of companies operating in this sector.
Returns
Trailing Returns (GBP)16/09/2021
YTD1.51
3 Years Annualised9.14
5 Years Annualised10.17
10 Years Annualised18.75
12 Month Yield 0.00
Management
Manager Name
Start Date
Rudi Van den Eynde
06/04/2000
Servaas Michielssens
01/01/2019
Inception Date
06/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Candriam Equities L Biotechnology Class C USD Cap31/07/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock96.240.0096.24
Bond0.000.000.00
Property0.000.000.00
Cash3.760.003.76
Other0.000.000.00
Top 5 Regions%
United States84.38
Eurozone5.08
Europe - ex Euro3.54
Asia - Emerging2.78
United Kingdom2.32
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare6.09
Vertex Pharmaceuticals IncHealthcareHealthcare5.43
Amgen IncHealthcareHealthcare5.07
Gilead Sciences IncHealthcareHealthcare4.85
Moderna IncHealthcareHealthcare4.66
Candriam Equities L Biotechnology Class C USD Cap

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement